U.S., Dec. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07279038) titled 'Pivotal U.S. Clinical Validation of AI-COA(R) for Depression and Anxiety' on Dec. 07.
Brief Summary: This study is a large-scale pivotal clinical validation of the AI-COA(R) software device. The purpose is to confirm the tool's accuracy and performance across a demographically diverse population of adults with Major Depressive Disorder (MDD), ensuring it functions fairly and reliably across different subgroups.
Study Start Date: March 01, 2027
Study Type: OBSERVATIONAL
Condition:
Depression Disorders
Anxiety Disorders
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Deliberate Solutions Inc.
Published by HT Digital Content Ser...